Cerebrospinal fluid levels of 5-hydroxyindoleacetic acid in Parkinson's disease and atypical parkinsonian syndromes

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F21%3A73608719" target="_blank" >RIV/61989592:15110/21:73608719 - isvavai.cz</a>

Alternative codes found

RIV/00843989:_____/21:E0109499 RIV/00098892:_____/21:N0000050

Result on the web

<a href="https://www.karger.com/Article/Abstract/520302" target="_blank" >https://www.karger.com/Article/Abstract/520302</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1159/000520302" target="_blank" >10.1159/000520302</a>

Result language

angličtina

Original language name

Cerebrospinal fluid levels of 5-hydroxyindoleacetic acid in Parkinson's disease and atypical parkinsonian syndromes

Original language description

Abstract Background: Various cerebrospinal fluid (CSF) biomarkers are studied in Parkinson&apos;s disease (PD) and atypical parkinsonian syndromes (APS). Several studies found reduced 5-hydroxyindoleacetic acid (5-HIAA), the main serotonin metabolite, in PD. There is little evidence regarding its levels in APS. Methods: We measured 5-HIAA in the CSF of 90 PD patients, 16 MSA patients, 26 progressive supranuclear palsy (PSP) patients, 11 corticobasal degeneration (CBD) patients, and 31 controls. We also compared the values in depressed and non-depressed patients. Results: There was a statistically significant difference in CSF 5-HIAA in PD and MSA compared to the control group (median in PD 15.8 µg/l, in MSA 13.6 µg/l vs. 24.3 µg/l in controls; P=0.0008 in PD, P=0.006 in MSA). There was no statistically significant difference in CSF 5-HIAA in PSP and CBD compared to the control group (median in PSP 22.7 µg/l, in CBD 18.7 µg/l vs. 24.3 µg/l in controls; P= 1 in both PSP and CBD). CSF 5-HIAA levels were lower in PD patients with depression compared to PD patients without depression (median 8.34 vs. 18.48, P&lt;0.0001). Conclusions: CSF 5-HIAA is decreased in PD and MSA. The CSF 5-HIAA levels in PSP and CBS did not differ from those of the control group. There was a tendency toward lower CSF 5-HIAA in MSA than in PD, however, the results did not reach statistical significance. These results may be explained by more severe damage of the serotonergic system in synucleinopathies (PD, MSA) than in tauopathies (PSP, CBS).

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30210 - Clinical neurology

Project

<a href="/en/project/EF16_019%2F0000868" target="_blank" >EF16_019/0000868: Molecular, cellular and clinical approach to healthy ageing</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2021

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Neurodegenerative Diseases

ISSN

1660-2854

e-ISSN

—

Volume of the periodical

21

Issue of the periodical within the volume

1-2

Country of publishing house

CH - SWITZERLAND

Number of pages

6

Pages from-to

30-35

UT code for WoS article

999

EID of the result in the Scopus database

2-s2.0-85121985982